-
Taxonomy & unit
-
us-gaap: shares
-
Description
-
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
-
Summary
-
Endonovo Therapeutics, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from Q1 2011 to Q3 2023.
- Endonovo Therapeutics, Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending September 30, 2023 was 298M shares, a 94.3% increase year-over-year.
- Endonovo Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 139M shares, a 133% increase from 2021.
- Endonovo Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2021 was 59.8M shares.
- Endonovo Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2012 was 48.1M shares, a 962% increase from 2011.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Growth (%)